Purchase this article with an account.
Andre Vicente, Barbara Borges, Rita Anjos, Ana Cabugueira, luisa vieira, Mariana Cardoso, Arnaldo Dias Santos, Nuno Silva, Joana Ferreira, Fernando Fernandes; Suprachoroidal Drainage Devices - Six Months Experience. Invest. Ophthalmol. Vis. Sci. 2014;55(13):6138.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the clinical outcomes of patients with suprachoroidal drainage devices.
The authors describe 4 cases of patients presenting with preoperative intraocular pressures (IOP) between 30-40 mmHg, under triple glaucoma medication and history of multiple intraocular surgeries, who underwent suprachoroidal drainage device (StarFlo®) implantation. The following parameters were evaluated: preoperative and postoperative IOP (1 day, 1 week and 1, 3 and 6 months), the use IOP-lowering medication and operative and post-operative complications. IOP reduction in over 30% or <21mmHg was considered relative or absolute success depending on whether this was achieved with or without use of further surgical intervention or medical IOP-lowering treatment, respectively.
At 3 months, there was a reduction in IOP greater than 30% to 3 months post-operative (Baseline IOP: 34 ± 2 mmHg, 3 months IOP: 13 ± 3 mmHg). After this period, IOP-lowering medication was re-started in 2 patients in order to sustain the higher than 30% IOP-lowering reduction. One of the patients with relative success criteria was lost in follow at 3 months. In our last observation, IOP remains lower than preoperative IOP (6 months IOP 13 ± 4 mmHg). No there were no complications during the procedure. A patient presented with hyphema in the first postoperative day, which spontaneously resolved.
Suprachoroidal drainage devices seem to reduce IOP significantly, are technically feasible and have few postoperative complications.
This PDF is available to Subscribers Only